Tokyo, Japan

Yusaku Hori

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Tsukuba, JP (2022)
  • Tokyo, JP (2023 - 2024)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yusaku Hori: Innovator in Cancer Treatment

Introduction

Yusaku Hori is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 4 patents, Hori's work focuses on innovative therapeutic compositions that aim to improve patient outcomes.

Latest Patents

Hori's latest patents include a tumor-treating pharmaceutical composition that combines lenvatinib with a specific compound designed to target tumors effectively. This composition is intended for use in combination therapy, enhancing the efficacy of existing treatments. Another notable patent involves a combination of a PD-1 antagonist and a multi-RTK inhibitor for treating cancer. This innovative approach aims to leverage the strengths of both therapies to provide a more effective treatment option for patients.

Career Highlights

Throughout his career, Hori has worked with leading companies in the pharmaceutical industry, including Eisai R&D Management Co., Ltd. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to develop groundbreaking therapies that address critical health challenges.

Collaborations

Hori has collaborated with notable professionals in his field, including Andrew Evan Denker and Yu Kato. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yusaku Hori's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the pharmaceutical industry. His contributions continue to pave the way for new therapeutic options that can significantly improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…